Table 1.
GOLD combined assessment and treatment of COPD.
Patient group | Exacerbations per year | CAT score | mMRC dyspnea scale score | Initial management |
---|---|---|---|---|
A | ≤1 | <10 | 0–1 | A bronchodilator |
B | ≤1 | ≥10 | ≥2 | LABA + LAMAa |
E | ≥2 Exacerbations per year or ≥1 with hospitalization | LABA + LAMAa consider LABA + LAMA + ICS if blood eos ≥300 |
Abbreviations: CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ICS, inhaled corticosteroid; LABA, long‐acting β2 agonist; LAMA, long‐acting anticholinergic; mMRC, modified Medical Research Council.
Single inhaler therapy may be more convenient and effective than multiple inhalers.